(No ratings)
Dr. Craig David Lotterman, MD is a physician provider in New Orleans, LA specializing in physician and pediatric oncology. He graduated from Chicago Medical School in 2003 and has 23 years of experience. Dr. Craig David Lotterman, MD is affiliated with Ochsner Health.
Dr. Craig David Lotterman, MD graduated from Chicago Medical School in 2003. He completed residency at NYU Pediatrics. He is certified by the general pediatrics as well as pediatric hematology and oncology by the American Board of Pediatrics and has a state license in Louisiana.
Medical School: Chicago Medical School (2003)
Residency: NYU Pediatrics (2006)
Board Certification: general pediatrics as well as pediatric hematology and oncology by the American Board of Pediatrics
Licensed In: Louisiana
Dr. Craig David Lotterman, MD does not have any reviews yet, be the first to leave a review of Dr. Craig David Lotterman, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Craig David Lotterman, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| Bayer HealthCare Pharmaceuticals Inc. |
$919
Vitrakvi $900 |
Jivi $19 |
||||
|---|---|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation |
$695
JADENU $224 |
PROMACTA $198 |
NON BRAND $105 |
Fabhalta $48 |
AFINITOR $44 |
Other $75 |
| Jazz Pharmaceuticals Inc. |
$636
Erwinaze $507 |
Defitelio $130 |
||||
| Pfizer Inc. |
$322
BENEFIX $152 |
OXBRYTA $71 |
HYMPAVZI $67 |
XYNTHA $32 |
||
| Y-mAbs Therapeutics, Inc. |
$304
DANYELZA $304 |
|||||
| Other |
$2,418
Nuwiq $216 |
GAMIFANT $209 |
LUCENTIS $134 |
KOSELUGO $117 |
NovoSeven RT $116 |
Other $1,625 |
| Food and Beverage | $4,131 |
|---|---|
| Consulting Fee | $900 |
| Education | $262 |
Dr. Craig David Lotterman, MD has received 11 research payments totaling $221,259.
Craig D. Lotterman, MD, specializes pediatric hematology oncology at Ochsner Health. They have a focus in pediatric cancers like brain cancers, kidney cancers, leukemia and other blood cancers, liver cancer, lymphoma, neuroblastoma, osteosarcoma and sarcoma. They coordinate treatments that include chemotherapy, radiation therapy, targeted therapy and immunotherapy.